For the year ending 2025-12-31, ANAB has $364,395K in assets. $238,196K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 238,196 | |||
| Receivables from collaborative partners | 33,850 | |||
| Short-term investments | 73,442 | |||
| Prepaid expenses and other current assets | 4,762 | |||
| Total current assets | 350,250 | |||
| Property and equipment, gross | 8,509 | |||
| Less accumulated depreciation and amortization | 7,139 | |||
| Property and equipment, net | 1,370 | |||
| Operating lease right-of-use assets | 12,519 | |||
| Long-term investments | 0 | |||
| Other long-term assets | 256 | |||
| Total assets | 364,395 | |||
| Accounts payable | 3,871 | |||
| Accrued expenses | 32,674 | |||
| Current portion of operating lease liability | 2,080 | |||
| Total current liabilities | 38,625 | |||
| Liability related to sale of future royalties | 276,528 | |||
| Operating lease liability, net of current portion | 12,032 | |||
| Common stock, 0.001 par value, 500,000 shares authorized, 28,019 shares and 30,473 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 28 | |||
| Additional paid in capital | 809,765 | |||
| Accumulated other comprehensive (loss) gain | -24 | |||
| Accumulated deficit | -772,559 | |||
| Total stockholders equity | 37,210 | |||
| Total liabilities and stockholders equity | 364,395 | |||
ANAPTYSBIO, INC (ANAB)
ANAPTYSBIO, INC (ANAB)